• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>HCP

HCP

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Airless Packaging Market - Analysis & Trends - Industry Forecast to 2025 - Research and Markets

    Global Airless Packaging Market - Analysis & Trends - Industry Forecast to 2025 - Research and Markets

  2. Lowering the Rent Shouldn't Hurt This Health-Care Landlord

    HCP remains one of the most attractive REITs we cover.

  3. Alnylam Receives European Medicines Agency PRIME Designation for Accelerated Assessment of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

    Alnylam Receives European Medicines Agency PRIME Designation for Accelerated Assessment of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias

  4. As Energy Demand Outpaces Supply, Asia Looks Overseas to Refuel

    Health Care Property HCP turned in an excellent second-quarter report in which revenue jumped 19%. Rising occupancies, inflation-based rent bumps, and additional rents from recent acquisitions boosted revenue growth significantly. Costs remain well-contained thanks to the company's triple-net lease ...

  5. Ventas Adds Value

    Ventas’ spin-off of skilled nursing facilities and Ardent acquisition add value for shareholders.

  6. New Wide Moats in Banks and Software

    We recently upgraded a few banks and enterprise software firms to wide moat status, and raised our fair value estimates on health-care REITs.

  7. Stock Market Outlook: Pick Your Spots Carefully

    Interest-rate fears bring utility and real estate valuations in line, but the broader market still looks fully valued.

  8. A Matter of Time for Health-Care REITs

    We prefer the yield, stability, and growth prospects of the triple-net structure over RIDEA.

  9. Reasonable Leverage, Growth Prospects, Moats, and Valuation Guide Our REIT Picks

    Our favorites can do well even with potentially higher interest rates.

1234

©2017 Morningstar Advisor. All right reserved.